
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Maltodextrin
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Jaguar Health
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Jaguar Licenses Oral Mucositis Product for U.S. Market in Cancer Care
Details : Gelclair will be commercialized by Jaguar Health in the U.S. to alleviate pain from oral lesions, including mucositis and stomatitis.
Product Name : Gelclair
Product Type : Miscellaneous
Upfront Cash : Undisclosed
April 16, 2024
Lead Product(s) : Maltodextrin
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Jaguar Health
Deal Size : Undisclosed
Deal Type : Licensing Agreement
